HIGHLIGHTS
SUMMARY
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) are a heterogeneous group of tumors arising from the enteroendocrine secretory cells of the gastrointestinal tract and endocrine pancreas. Analyses have found significant differences in the rate of metastatic disease among racial groups, with Black patients having the highest rate of advanced stage/metastatic disease in pancreatic, gastric, and appendiceal, NENs (36.3%, 20.9%, and 13.5%), followed by White patients (34% 16.7%, 12.1%), Hispanic/Latinx patients (28.2%, 15.1%, 5.65%), and Asian patients (26.7%, 16.7%, 19.8%; ref 3). Given this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.